Superworth

Specialty and generic drugmakers

The 3 specialty and generic drugmakers we cover, part of healthcare, largest first. Numbers as of .

Companies
3
Combined market cap
$105.5B
Median PE
42.4×
Median revenue growth
+2.8%
Median net margin
15.8%
CompanyMarket capPEP/SRevenue growthNet marginDividend yield
TEVATeva Pharmaceutical Industries$49.7B71.1×2.9×+4%4.1%n/m
ZTSZoetis$34.3B13.7×3.6×+1%27.5%2.52%
VTRSViatriscaveat$21.4Bn/m1.5×+4%−2.8%n/m

Other industries in Healthcare

Valuation data, not investment advice. Each company's page has its story, charts, financials and peers.